financetom
Business
financetom
/
Business
/
Descartes Systems Group Drops 6.1% After Hours as its Q4 Profit Rises on Higher Sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Descartes Systems Group Drops 6.1% After Hours as its Q4 Profit Rises on Higher Sales
Mar 6, 2024 2:23 PM

05:12 PM EST, 03/06/2024 (MT Newswires) -- Descartes Systems Group ( DSGX ) was down 6.1% in after-hours Nasdaq trading after it on Wednesday said its fourth-quarter profit rose 6.7% on higher sales.

The logistics-software company said it earned US$31.8 million, or US$0.37 per share, in the period, up from US$29.8 million, or US$0.34, in the year-prior quarter.

Revenue rose 18% to US$148.2-million from US$125.1 million.

"Global trade continues to be impacted by military conflicts, disruptions to major shipping routes and a growing list of sanctions from various governments around the world. Our Global Logistics Network is designed to help shippers, carriers and logistics services providers adapt their supply chains to efficiently manage the lifecycle of shipments in this increasingly dynamic landscape. As a result, our customers are trusting us with more of their business which puts us in a strong financial position to continue to invest in our business," chief executive Edward Ryan said in a release.

Descartes shares were last seen down US$5.32 to US$82.00 in after-hours trading. They closed up C$2.51 to C$117.90 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Mar 17, 2025
08:22 AM EDT, 03/17/2025 (MT Newswires) -- Precision BioSciences ( DTIL ) said Monday its investigational new drug application for PBGENE-HBV in vivo gene editing program has received the US Food and Drug Administration's clearance to treat chronic hepatitis B. The company is in final stages of US site activation to start enrolling participants in its Eliminate-B study in the...
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Mar 17, 2025
08:25 AM EDT, 03/17/2025 (MT Newswires) -- Amazon.com ( AMZN ) plans to expand its Alexa device line with a premium tier in a bid to offer consumers more choices, Bloomberg reported Monday, citing the company's head for devices and services Panos Panay. Panay told the news outlet that the voice assistant's new artificial intelligence operating system, Alexa+, will be...
Stellantis invests $41 million in Italy to make EV engine parts
Stellantis invests $41 million in Italy to make EV engine parts
Mar 17, 2025
MILAN (Reuters) - Automaker Stellantis is investing 38 million euros ($41 million) in its Verrone plant in Northern Italy to manufacture parts for electric engines for its upcoming small-size models, it said on Monday. The plant will manufacture steel components for electric drive modules Stellantis ( STLA ) currently makes in other European facilities, the company said in a statement,...
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Mar 17, 2025
08:16 AM EDT, 03/17/2025 (MT Newswires) -- Monogram Technologies ( MGRM ) said Monday that its robotic-assisted total knee arthroplasty system, the Monogram mBos TKA System, has received a 510(k) clearance from the US Food and Drug Administration. Monogram Technologies ( MGRM ) said the approval allows to market the device, subject to the requirements of the Federal Food, Drug,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved